Peter M Hecht - Net Worth and Insider Trading
Peter M Hecht Net Worth
The estimated net worth of Peter M Hecht is at least $39 Million dollars as of 2024-04-26. Peter M Hecht is the CEO of Ironwood Pharmaceuticals Inc and owns about 4,731,916 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $38 Million. Peter M Hecht is also the CEO of Cyclerion Therapeutics Inc and owns about 102,458 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $311,472. Details can be seen in Peter M Hecht's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter M Hecht has not made any transactions after 2021-06-03 and currently still holds the listed stock(s).
Transaction Summary of Peter M Hecht
Peter M Hecht Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter M Hecht owns 2 companies in total, including Cyclerion Therapeutics Inc () , and Ironwood Pharmaceuticals Inc () .
Click here to see the complete history of Peter M Hecht’s form 4 insider trades.
Insider Ownership Summary of Peter M Hecht
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Cyclerion Therapeutics Inc | 2021-06-03 | director & Chief Executive Officer | |
| Ironwood Pharmaceuticals Inc | 2019-01-25 | director & Chief Executive Officer |
Peter M Hecht Latest Holdings Summary
Peter M Hecht currently owns a total of 2 stocks. Among these stocks, Peter M Hecht owns 4,731,916 shares of Ironwood Pharmaceuticals Inc (IRWD) as of January 25, 2019, with a value of $38 Million and a weighting of 99.19%. Peter M Hecht also owns 102,458 shares of Cyclerion Therapeutics Inc (CYCN) as of June 3, 2021, with a value of $311,472 and a weighting of 0.81%.
Latest Holdings of Peter M Hecht
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2019-01-25 | 4,731,916 | 8.08 | 38,233,881 |
| CYCN | Cyclerion Therapeutics Inc | 2021-06-03 | 102,458 | 3.04 | 311,472 |
Holding Weightings of Peter M Hecht
Peter M Hecht Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter M Hecht has made a total of 0 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 89,551 shares on January 25, 2019, which brought Peter M Hecht around $1 Million.
According to the SEC Form 4 filings, Peter M Hecht has made a total of 3 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cyclerion Therapeutics Inc is the acquisition of 41,159 shares on June 3, 2021, which cost Peter M Hecht around $3 Million.
Insider Trading History of Peter M Hecht
- 1
Peter M Hecht Trading Performance
GuruFocus tracks the stock performance after each of Peter M Hecht's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter M Hecht is 16.91%. GuruFocus also compares Peter M Hecht's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter M Hecht within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter M Hecht's insider trading performs compared to the benchmark.
Performance of Peter M Hecht
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.82 | 16.91 | 3.21 | -60.98 | -50.38 | -0.46 |
| Relative Return to S&P 500(%) | 15.47 | 10.24 | -8.46 | -65.99 | -55.23 | -14.46 |
Peter M Hecht Ownership Network
Ownership Network List of Peter M Hecht
Ownership Network Relation of Peter M Hecht
Peter M Hecht Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Peter M Hecht is the director & Chief Executive Officer of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , 10 percent owner Slate Path Capital Lp , and Chief Financial Officer Anjeza Gjino .
Cyclerion Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Peter M Hecht made no insider transaction in Cyclerion Therapeutics Inc (). Other recent insider transactions involving Cyclerion Therapeutics Inc () include a net sale of 8 shares made by Terrance Mcguire ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.
Cyclerion Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Peter M Hecht Mailing Address
Above is the net worth, insider trading, and ownership report for Peter M Hecht. You might contact Peter M Hecht via mailing address: C/o Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
